Itolizumab is a humanized recombinant monoclonal antibody specifically targeting the extracellular SRCR distal domain 1 of the CD6 antigen. This antibody effectively reduces T-cell proliferation and modulates immune response by inhibiting the production of key pro-inflammatory cytokines, including INF-??, TNF??, and IL-6. Due to its specific action on immune modulation, Itolizumab is extensively utilized in research focused on inflammatory and autoimmune conditions such as psoriasis and rheumatoid arthritis, as well as in studies exploring therapeutic approaches for COVID-19.
Itolizumab is a humanized recombinant monoclonal antibody specifically targeting the extracellular SRCR distal domain 1 of the CD6 antigen. This antibody effectively reduces T-cell proliferation and modulates immune response by inhibiting the production of key pro-inflammatory cytokines, including INF-??, TNF??, and IL-6. Due to its specific action on immune modulation, Itolizumab is extensively utilized in research focused on inflammatory and autoimmune conditions such as psoriasis and rheumatoid arthritis, as well as in studies exploring therapeutic approaches for COVID-19.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
